• PROGENICS PHARMACEUTICALS IN Earnings Analysis

  • Earnings Summary: PGNX

    EPS (TTM): -1.73 Current P/E Ratio: -9.17341
    Last Quarter's Earnings: -0.08 Current Quarter Estimate: -0.277
    Last Fiscal Year Earnings: -1.60 Next Fiscal Year Estimate: -1.449
    Analyst Consensus: Buy Dividend Rate: 0.00
    Last Dividend: 0.00
  • Reported Quarters: PGNX

    Quarterly EPS millions
  • Seasonal Performance: PGNX